1. De-risking primary and secondary pharmacology mediated adverse effects as a path to increase likelihood of success in drug development. (20th October 2017) Authors: Valentin, Jean-Pierre; Atienzar, Franck; Class, Reiner; Delaunois, Annie; Fleurance, Renaud; Gerets, Helga; Glineur, Stéphanie; Gryshkova, Vitalina; Hall, Peter; Hasselgren, Catrin; Tilmant, Karen Journal: Toxicology letters Issue: Volume 280(2017)Supplement 1 Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: is aromatic N-oxide a structural alert for predicting DNA-reactive mutagenicity?*. (5th September 2018) Authors: Amberg, Alexander; Anger, Lennart T; Bercu, Joel; Bower, David; Cross, Kevin P; Custer, Laura; Harvey, James S; Hasselgren, Catrin; Honma, Masamitsu; Johnson, Candice; Jolly, Robert; Kenyon, Michelle O; Kruhlak, Naomi L; Leavitt, Penny; Quigley, Donald P; Miller, Scott; Snodin, David; Stavitskaya... Journal: Mutagenesis Issue: Volume 34:Number 1(2019) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In silico toxicology protocols and software platforms. (20th October 2017) Authors: Myatt, Glenn; Bower, David; Cross, Kevin; Hasselgren, Catrin; Miller, Scott; Quigley, Donald Journal: Toxicology letters Issue: Volume 280(2017)Supplement 1 Page Start: S286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Methodologies for a better expert review supporting implementation of the ICH M7 guidelines. (20th October 2017) Authors: Hasselgren, Catrin; Bower, David; Cross, Kevin; Miller, Scott; Quigley, Donald; Myatt, Glenn Journal: Toxicology letters Issue: Volume 280(2017)Supplement 1 Page Start: S287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗